DRD2 and red-green color blindness: Klaffke et al. reported contralateral hypometabolism in multiple cortical and subcortical regions in patients with CBD, while 123I-iodobenzamide (IBZM) SPECT imaging revealed reduced dopamine D2 receptor binding in only one patient, suggesting limited sensitivity of IBZM in detecting basal ganglia involvement in CBD [37].